These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26892667)

  • 41. The First Step to Integrating Adapted Common Terminology Criteria for Adverse Events for Children.
    de Rojas T; Bautista FJ; Madero L; Moreno L
    J Clin Oncol; 2016 Jun; 34(18):2196-7. PubMed ID: 27114600
    [No Abstract]   [Full Text] [Related]  

  • 42. Agreement Among Paper and Electronic Modes of the EQ-5D-5L.
    Lundy JJ; Coons SJ; Flood E; Patel MJ;
    Patient; 2020 Aug; 13(4):435-443. PubMed ID: 32346816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug development.
    Xia H; Booth BP; Wang Y; Fan C; Bhatnagar V; Kluetz P; Fourie Zirkelbach J
    J Patient Rep Outcomes; 2023 Nov; 7(1):116. PubMed ID: 37975967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dutch translation and linguistic validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™).
    Veldhuijzen E; Walraven I; Mitchell SA; Moore EY; McKown SM; Lauritzen M; Kim KJ; Belderbos JSA; Aaronson NK
    J Patient Rep Outcomes; 2020 Oct; 4(1):81. PubMed ID: 33025309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of quality of life using a tablet PC-based survey in cancer patients treated with radiotherapy: a multi-institutional prospective randomized crossover comparison of paper and tablet PC-based questionnaires (KROG 12-01).
    Kim H; Park HC; Yoon SM; Kim TH; Kim J; Kang MK; Jung J; Kim SW; Yea JW; Park SH; Park YS
    Support Care Cancer; 2016 Oct; 24(10):4399-406. PubMed ID: 27220523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Test-Retest Reliability of an Interactive Voice Response (IVR) Version of the EORTC QLQ-C30.
    Lundy JJ; Coons SJ; Aaronson NK
    Patient; 2015 Apr; 8(2):165-70. PubMed ID: 24958466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.
    Reeve BB; McFatrich M; Pinheiro LC; Freyer DR; Basch EM; Baker JN; Withycombe JS; Sung L; Mack JW; Waldron MK; Mowbray C; Palma D; Hinds PS
    J Pain Symptom Manage; 2017 Apr; 53(4):759-766. PubMed ID: 28062347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.
    Reeve BB; McFatrich M; Mack JW; Maurer SH; Jacobs SS; Freyer DR; Withycombe JS; Baker JN; Castellino SM; Lin L; Lucas NR; Hinds PS
    J Natl Cancer Inst; 2020 Nov; 112(11):1143-1152. PubMed ID: 31999349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients.
    Baeksted C; Pappot H; Nissen A; Hjollund NH; Mitchell SA; Basch E; Bidstrup PE; Dalton SO; Johansen C
    J Patient Rep Outcomes; 2017; 1(1):1. PubMed ID: 29757324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review.
    Atkinson TM; Ryan SJ; Bennett AV; Stover AM; Saracino RM; Rogak LJ; Jewell ST; Matsoukas K; Li Y; Basch E
    Support Care Cancer; 2016 Aug; 24(8):3669-76. PubMed ID: 27260018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.
    Marcano Belisario JS; Jamsek J; Huckvale K; O'Donoghue J; Morrison CP; Car J
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):MR000042. PubMed ID: 26212714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.
    Reeve BB; McFatrich M; Lin L; Lucas NR; Mack JW; Jacobs SS; Withycombe JS; Baker JN; Freyer DR; Hinds PS
    Cancer; 2021 May; 127(9):1483-1494. PubMed ID: 33332590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach.
    Gilbert A; Francischetto EO; Blazeby J; Holch P; Davidson S; Sebag-Montefiore D; Velikova G
    Lancet; 2015 Feb; 385 Suppl 1():S38. PubMed ID: 26312860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients.
    Holch P; Warrington L; Potrata B; Ziegler L; Hector C; Keding A; Harley C; Absolom K; Morris C; Bamforth L; Velikova G
    Acta Oncol; 2016; 55(9-10):1220-1226. PubMed ID: 27551774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Equivalence testing of a newly developed interviewer-led telephone script for the EORTC QLQ-C30.
    Piccinin C; Pe M; Kuliś D; Shaw JW; Wheelwright SJ; Bottomley A
    Qual Life Res; 2022 Mar; 31(3):877-888. PubMed ID: 34286416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Japanese translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Miyaji T; Iioka Y; Kuroda Y; Yamamoto D; Iwase S; Goto Y; Tsuboi M; Odagiri H; Tsubota Y; Kawaguchi T; Sakata N; Basch E; Yamaguchi T
    J Patient Rep Outcomes; 2017; 1(1):8. PubMed ID: 29757296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy.
    Christiansen MG; Pappot H; Jensen PT; Mirza MR; Jarden M; Piil K
    J Patient Rep Outcomes; 2023 Jul; 7(1):72. PubMed ID: 37462855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.
    Basch E; Dueck AC; Rogak LJ; Mitchell SA; Minasian LM; Denicoff AM; Wind JK; Shaw MC; Heon N; Shi Q; Ginos B; Nelson GD; Meyers JP; Chang GJ; Mamon HJ; Weiser MR; Kolevska T; Reeve BB; Bruner DW; Schrag D
    J Clin Oncol; 2018 Sep; 36(31):JCO2018788620. PubMed ID: 30204536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
    Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
    JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.